Abstract
Autologous transplantation of gene-modified hematopoietic stem and progenitor cells (HPC) is currently evaluated for treatment of monogeneic hematopoietic disorders. Clinical studies have successfully used retroviral gene transfer into HPC to correct X-linked severe combined immunodeficiency (X-SCID) [1, 2]. We currently evaluate gene transfer into HPC for hemophilia A gene therapy. Transplantation of HPC transduced with a gene for coagulation factor VIII (FVIII) may potentially provide a permanent pool of FVIII-expressing hematopoietic cells. In addition, immune tolerance against neo-antigenic FVIII might be achieved as reported for other transgenes in animal models. However, it has been unclear whether cells of hematopoietic origin are capable of FVIII biosynthesis and secretion, because transplantation of FVIII-transduced bone marrow cells into conditioned mice did not result in the expression of detectable FVIII in the plasma [3, 4]. Others have found that certain myeloid cell lines were able to efficiently produce FVIII after transduction in vitro [5, 6]. We therefore studied the expression of recombinant FVIII after gene transfer into various hematopoietic cell types.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P, Selz F, Hue C, Certain S, Casanova JL, Bousso P, Deist FL, Fischer A. Gene therapy of human severe com-bined immunodeficiency (SCID)-X1 disease. Science 2000; 288: 669–672
Hacein-Bey-Abina S, Le Deist F, Carlier F, Bouneaud C, Hue C, De Villartay JP, Thrasher AJ, Wulffraat N, Sorensen R, Dupuis-Girod S, Fischer A, Davies EG, Kuis W, Leiva L, Cavazzana-Calvo M. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 2002; 346: 1185–1193
Hoeben RC, Einerhand MP, Briet E, van Ormondt H, Valerio D, van der Eb AJ. Toward gene therapy in hemophilia A: retrovirus-mediated transfer of a factor VIII gene into murine hematopoietic progenitor cells. Thromb Haemost 1992; 67: 341–345
Evans GL, Morgan RA. Genetic induction of immune tolerance to human clotting factor VIII in a mouse model for hemophilia A. Proc Natl Acad Sci U S A 1998; 95: 5734–5739
Tonn T, Becker S, Herder C, Grez M, Seifried E. Hematopoietic stem cells as targets for gene therapy of hemophilia A. In: Scharrer I, Schramm W, eds. 32nd Hemophilia Symposium: Hamburg 2001. Springer Verlag Berlin, Heidelberg; 2001: 61–71
Tonn T, Herder C, Becker S, Seifried E, Grez M. Generation and Characterization of Human Hematopoietic Cell Lines Expressing Factor VIII. J Hematother Stem Cell Res 2002; 11: 695–704
Cameron C, Notley C, Hoyle S, McGlynn L, Hough C, Kamisue S, Giles A, Lillicrap D. The canine factor VIII cDNA and 5′ flanking sequence. Thromb Haemost 1998; 79: 317–322
Naldini L, Blömer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272: 263–267
Scherr M, Battmer K, Blömer U, Schiedlmeier B, Ganser A, Grez M, Eder M. Lentiviral gene transfer into peripheral blood-derived CD34+ NOD/SCID-repopulating cells. Blood 2002; 99: 709–712
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Tiede, A., Eder, M., Scherr, M., Ganser, A., von Depka Prondzinski, M. (2004). Experimental Approaches to Hemophilia Gene Therapy: Gene Transfer into Hematopoietic Stem Cells. In: Scharrer, I., Schramm, W. (eds) 33rd Hemophilia Symposium. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18260-0_21
Download citation
DOI: https://doi.org/10.1007/978-3-642-18260-0_21
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-00902-3
Online ISBN: 978-3-642-18260-0
eBook Packages: Springer Book Archive